Troubleshooting computational methods in drug discovery
- PMID: 20176118
- DOI: 10.1016/j.vascn.2010.02.005
Troubleshooting computational methods in drug discovery
Abstract
Computational approaches for drug discovery such as ligand-based and structure-based methods, are increasingly seen as an efficient approach for lead discovery as well as providing insights on absorption, distribution, metabolism, excretion and toxicity (ADME/Tox). What is perhaps less well known and widely described are the limitations of the different technologies. We have therefore presented a troubleshooting approach to QSAR, homology modeling, docking as well as hybrid methods. If such computational or cheminformatics methods are to become more widely used by non-experts it is critical that such limitations are brought to the user's attention and addressed during their workflows. This could improve the quality of the models and results that are obtained.
Copyright 2010 Elsevier Inc. All rights reserved.
Similar articles
-
Toxicology Strategies for Drug Discovery: Present and Future.Chem Res Toxicol. 2016 Apr 18;29(4):473-504. doi: 10.1021/acs.chemrestox.5b00407. Epub 2015 Dec 4. Chem Res Toxicol. 2016. PMID: 26588328 Review.
-
In silico toxicology for the pharmaceutical sciences.Toxicol Appl Pharmacol. 2009 Dec 15;241(3):356-70. doi: 10.1016/j.taap.2009.08.022. Epub 2009 Aug 28. Toxicol Appl Pharmacol. 2009. PMID: 19716836 Review.
-
Open Source Bayesian Models. 1. Application to ADME/Tox and Drug Discovery Datasets.J Chem Inf Model. 2015 Jun 22;55(6):1231-45. doi: 10.1021/acs.jcim.5b00143. Epub 2015 Jun 3. J Chem Inf Model. 2015. PMID: 25994950 Free PMC article.
-
Mind the Gap! A Journey towards Computational Toxicology.Mol Inform. 2016 Sep;35(8-9):294-308. doi: 10.1002/minf.201501017. Epub 2016 Apr 13. Mol Inform. 2016. PMID: 27546034 Review.
-
Toxicology Strategies for Drug Discovery - Present and Future: Introduction.Chem Res Toxicol. 2016 Apr 18;29(4):437. doi: 10.1021/acs.chemrestox.6b00049. Chem Res Toxicol. 2016. PMID: 27087588 Free PMC article. No abstract available.
Cited by
-
Human immunodeficiency virus protease inhibitors interact with ATP binding cassette transporter 4/multidrug resistance protein 4: a basis for unanticipated enhanced cytotoxicity.Mol Pharmacol. 2013 Sep;84(3):361-71. doi: 10.1124/mol.113.086967. Epub 2013 Jun 17. Mol Pharmacol. 2013. PMID: 23775562 Free PMC article.
-
Computational Approaches for Predicting Drug Interactions with Human Organic Anion Transporter 4 (OAT4).Mol Pharm. 2025 Apr 7;22(4):1847-1858. doi: 10.1021/acs.molpharmaceut.4c00984. Epub 2025 Mar 20. Mol Pharm. 2025. PMID: 40112155
-
Computational databases, pathway and cheminformatics tools for tuberculosis drug discovery.Trends Microbiol. 2011 Feb;19(2):65-74. doi: 10.1016/j.tim.2010.10.005. Epub 2010 Dec 2. Trends Microbiol. 2011. PMID: 21129975 Free PMC article. Review.
-
Free energy landscape for the binding process of Huperzine A to acetylcholinesterase.Proc Natl Acad Sci U S A. 2013 Mar 12;110(11):4273-8. doi: 10.1073/pnas.1301814110. Epub 2013 Feb 25. Proc Natl Acad Sci U S A. 2013. PMID: 23440190 Free PMC article.
-
Inhibitors of Helicobacter pylori protease HtrA found by 'virtual ligand' screening combat bacterial invasion of epithelia.PLoS One. 2011 Mar 31;6(3):e17986. doi: 10.1371/journal.pone.0017986. PLoS One. 2011. PMID: 21483848 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources